Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Giannou

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Gut|January 14, 2021
Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett's carcinomaHanno Ehlken, Rüdiger Schmitz, Sabine Riethdorf, et al.
International Journal of Oncology|November 16, 2022
Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigeninLouisa Stern, Lukas Fabian Boehme, Mara Rebecca Goetz, et al.
Gastro Hep Advances|December 9, 2025
Blockade of Interleukin-6 Trans-signaling in the Presence of Certain Gut Microbiota Induces Mature-onset Obesity in MiceTali Lanton, Dana Eidelshtein, Jacob Rachmilewitz, et al.
Scientific Reports|May 19, 2026
Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humansFabian Heinrich, Jöran Lücke, Siwen Zhang, et al.
Nature Communications|November 7, 2020
Publisher Correction: TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.
Nature Communications|May 27, 2020
TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2023
Tr1 Cells Emerge and Suppress Effector Th17 Cells in GlomerulonephritisShiwa Soukou-Wargalla, Christoph Kilian, Lis N Velasquez, et al.
Annals of Hepatology|October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumabLorenz Kocheise, Jan Kempski, Yunhe Tang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Gut|January 14, 2021
Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett's carcinomaHanno Ehlken, Rüdiger Schmitz, Sabine Riethdorf, et al.
International Journal of Oncology|November 16, 2022
Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigeninLouisa Stern, Lukas Fabian Boehme, Mara Rebecca Goetz, et al.
Gastro Hep Advances|December 9, 2025
Blockade of Interleukin-6 Trans-signaling in the Presence of Certain Gut Microbiota Induces Mature-onset Obesity in MiceTali Lanton, Dana Eidelshtein, Jacob Rachmilewitz, et al.
Scientific Reports|May 19, 2026
Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humansFabian Heinrich, Jöran Lücke, Siwen Zhang, et al.
Nature Communications|November 7, 2020
Publisher Correction: TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.
Nature Communications|May 27, 2020
TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2023
Tr1 Cells Emerge and Suppress Effector Th17 Cells in GlomerulonephritisShiwa Soukou-Wargalla, Christoph Kilian, Lis N Velasquez, et al.
Annals of Hepatology|October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumabLorenz Kocheise, Jan Kempski, Yunhe Tang, et al.
Pageof 2